Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/08/2005WO2005074925A8 Compositions substantially free of galactomannan containing piperacillin and tazobactam
12/08/2005WO2005074884A3 Sustained release pharmaceutical composition of indapamide
12/08/2005WO2005069886A8 Sparsely cross-linked nanogels: a novel polymer structure for microchannel dna sequencing
12/08/2005WO2005065648A3 Novel drug compositions and dosage forms of topiramate
12/08/2005WO2005065647A3 Drug granule coatings that impart smear resistance during mechanical compression
12/08/2005WO2005065646A3 Novel drug compositions and dosage forms
12/08/2005WO2005065640A8 Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
12/08/2005WO2005063204A3 Drug delivery device with suture ring
12/08/2005WO2005051232A3 Soft tissue implants and anti-scarring agents
12/08/2005WO2005042142A8 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
12/08/2005WO2005037246A3 Aqueous aerosol preparation
12/08/2005WO2005011580A3 Compositions and methods for herpes simplex prophylaxis and treatment
12/08/2005WO2005011578A2 Preoperative treatment of post operative pain
12/08/2005WO2005001906A3 Materials and methods for near-infrared and infrared lymph node mapping
12/08/2005WO2004100935A3 Propofol formulation containing reduced oil and surfactants
12/08/2005WO2004066704A3 Injectable hydrogel microspheres from aqueous two-phase system
12/08/2005WO2004060447A3 Transdermal delivery using encapsulated agent activated by ultrasound and/or heat
12/08/2005US20050273178 Load bearing biocompatible device
12/08/2005US20050273083 Implantable medication delivery device using pressure regulator
12/08/2005US20050273081 Regulator
12/08/2005US20050273080 Methods and systems for providing an interface between an ambulatory medical device and a display device
12/08/2005US20050273079 Fluid material dispensing syringe
12/08/2005US20050273047 System and method for transdermal delivery of an anticoagulant
12/08/2005US20050273046 Transdermal delivery of therapeutic agent
12/08/2005US20050272878 Polymeric compositions for sustained release of volatile materials
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272806 Injectable formulations of taxanes for cad treatment
12/08/2005US20050272796 Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
12/08/2005US20050272795 Prevention and treatment of benign prostatic hyperplasia
12/08/2005US20050272790 Galenic formulations of organic compounds
12/08/2005US20050272768 Process for preparation of amorphous form of a drug
12/08/2005US20050272714 Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272685 Intraductal treatment targeting methylated promoters in breast cancer
12/08/2005US20050272677 Delivery of a substance to a pre-determined site
12/08/2005US20050272644 Method for increasing therapeutic gain in radiotherapy and chemotherapy
12/08/2005US20050272638 Improved bioavailability; for oral and intracolonic administration
12/08/2005US20050271778 Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof
12/08/2005US20050271758 Topical compositions containing Bacillus coagulans extracellular products and uses thereof
12/08/2005US20050271752 Antifungal products and method of use
12/08/2005US20050271750 Topical formulation for prevention and treatment of acne
12/08/2005US20050271748 Compositions for treating hyperemia
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271737 Determination morphology of active material; applying bioactive material as drops to substrate; evaporation
12/08/2005US20050271735 Method of encapsulating hydrophobic organic molecules in polyurea capsules
12/08/2005US20050271734 Detoxification and decontamination using nanotechnology therapy
12/08/2005US20050271733 Particle delivery techniques
12/08/2005US20050271732 Delivery of bioactive substances to target cells
12/08/2005US20050271731 Process for the production of microspheres and unit therefor
12/08/2005US20050271730 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances
12/08/2005US20050271729 Via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide methiodide; freeze drying
12/08/2005US20050271728 High molecular weight medicine-containing preparation in powder form for administration through mucosa
12/08/2005US20050271727 Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures
12/08/2005US20050271726 Immune enhancing compositions and methods of use thereof
12/08/2005US20050271725 Adhesive gel composition for iontophoresis preparation and process for producing the same
12/08/2005US20050271724 Sugar coatings and methods therefor
12/08/2005US20050271723 Dosage forms for treatment of benign prostatic hyperplasia
12/08/2005US20050271722 complex composed of a protein and/or peptide and a gallic acid ester that allow for sustained delivery of the protein or peptide in vivo upon administration of the complex; gallic acid ester is epigallocatechin gallate
12/08/2005US20050271721 Carvedilol-hydrophilic solutions
12/08/2005US20050271720 Pharmaceutical composition containing irbesartan
12/08/2005US20050271719 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
12/08/2005US20050271718 Sustained release propafenone hydrochloride capsules
12/08/2005US20050271717 Dry-granulated dosage forms of tablets or capsules; preparation by compressing the mixture, milling, grinding or sieving the compressed material; hypercholesterolemia, hyperlipidemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's disease
12/08/2005US20050271716 Preparation containing basic drug
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005US20050271714 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome
12/08/2005US20050271713 Topical anesthetic preparation for pretreatment for upper gastrointestinal endoscopy
12/08/2005US20050271712 Multilayer wound covering and therapeutic methods thereof
12/08/2005US20050271711 Therapeutic antimicrobial compositions and methods
12/08/2005US20050271708 Palatable controlled-release formulation for companion animals
12/08/2005US20050271707 Dry powder; administering through feeding tube
12/08/2005US20050271706 Longitudinal body with polymeric coating; triamcinolone acetonide; drug delivery to eye
12/08/2005US20050271705 Retinoid-containing sustained release intraocular drug delivery system and related methods
12/08/2005US20050271703 Controlled release bioactive agent delivery device
12/08/2005US20050271702 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein about 3%-5% (w/w) exendin-4 and about 2% (w/w) sucrose; antidiabetic agent
12/08/2005US20050271699 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
12/08/2005US20050271691 Prepackaged aqueous pharmaceutical formulations
12/08/2005US20050271645 combination of lysozyme with an antibiotic: Ampicillin, Sulbactam, Cefotaxime, Ceftriaxone, Cefepime, Imipenem, Meropenem, Piperacillin, Tazobactam, Azithromycin, Clarithromycin, Erythromycin, Vancomycin, Clindamycin, Gatofloxicin, Levofloxacin, Moxifloxacin, Ciprofloxacin etc. to treat pneumonia
12/08/2005US20050271618 Methods of reducing aggregation of IL-1ra
12/08/2005US20050271599 Foamed cleanser with suspended particles
12/08/2005US20050271598 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/08/2005US20050271597 Prostate hypertrophy treatment composition and method
12/08/2005US20050271594 Abuse resistent pharmaceutical composition
12/08/2005US20050271588 Liposome targeting of matrix metalloproteinase inhibitors
12/08/2005US20050271571 Hydroxapatite calcium phosphates, their method of preparation and their applications
12/08/2005US20050269722 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
12/08/2005US20050269546 Valve with a two-component seal
12/08/2005US20050269433 Method for producing small granules
12/08/2005DE19932216B4 Teilchen, insbesondere Mikroteilchen oder Nanoteilchen, aus vernetzten Monosacchariden und Oligosacchariden, Verfahren zu deren Herstellung und Verwendung der Teilchen als kosmetisches Mittel oder zur Herstellung pharmazeutischer Zusammensetzungen oder Nahrungsmittelzusammensetzungen Particles, in particular microparticles or nanoparticles of crosslinked monosaccharides and oligosaccharides, a process for their preparation and use of the particles as a cosmetic agent or for the preparation of pharmaceutical compositions or food compositions
12/08/2005DE102004023984A1 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol Film-shaped, orally administrable pharmaceutical composition containing estriol
12/08/2005DE102004023930A1 Schnell lösliches Granulat von Bromhexin/Bromhexinhydrochlorid, Verfahren zu dessen Herstellung und dessen Verwendung Fast-dissolving granules of bromhexine / bromhexine hydrochloride, processes for its preparation and its use
12/08/2005DE102004023828A1 Lösung für die Peritonealdialyse Solution for peritoneal dialysis
12/08/2005DE102004023069A1 Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil New dosage forms of the PDE 5 inhibitor vardenafil
12/08/2005DE102004022928A1 Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung Powder containing Oligosacharidgemische novel and processes for their preparation
12/08/2005CA2824612A1 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
12/08/2005CA2772033A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2772029A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771951A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771941A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771940A1 Compositions and methods for bone formation and remodeling
1 ... 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 ... 2991